Literature DB >> 16793947

Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening.

Emil Hagström1, Ewa Lundgren, Jonas Rastad, Per Hellman.   

Abstract

OBJECTIVE: Dyslipidemia, hypertension, diabetes mellitus and also primary hyperparathyroidism (pHPT) are associated with an increased risk of cardiovascular diseases. Metabolic abnormalities in mild pHPT have been reported, but never in cases with normal calcium and high parathyroid hormone (PTH) levels, i.e. suffering from 'normocalcemic pHPT'. Our aim was to explore the occurrence of these metabolic abnormalities in individuals with normocalcemic pHPT identified in a population-based screening, and the effects of parathyroidectomy vs conservative treatment on metabolic variables. DESIGN AND METHODS: A population-based screening of 5202 post-menopausal women identified 30 patients with normal calcium, inappropriately high PTH and normal creatinine. A 5-year follow-up included 15 parathyroidectomized (PTx) and nine conservatively followed cases, in a non-randomized setting, together with age-matched controls. Biochemical variables and body mass index (BMI) were investigated.
RESULTS: At study entry, cases had higher calcium, PTH, glucose, low-density lipoprotein (LDL)/high-density lipoprotein (HDL)-cholesterol, very low-density lipoprotein (VLDL)-cholesterol, total triglycerides, and BMI compared to controls (P = < 0.0001-0.035). The cases had a lower HDL-cholesterol value (P = 0.013) and one third of the cases had hypertriglyceridemia. During follow-up, the PTx cases decreased in calcium, PTH, LDL/HDL-cholesterol, total and LDL-cholesterol (P = 0.0076-0.022). Investigated biochemical variables remained adverse in conservatively followed cases during follow-up except a decreased LDL-cholesterol value. All surgically treated patients had parathyroid adenoma.
CONCLUSIONS: Cases with normocalcemic pHPT have increased proatherogenic lipoprotein levels, BMI and glucose levels compared to age-matched controls. Parathyroidectomy has positive effects on some of these variables and reverses them to the same level as the controls, while conservative treatment fails to normalize the investigated metabolic variables.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16793947     DOI: 10.1530/eje.1.02173

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  20 in total

1.  Glucose intolerance and primary hyperparathyroidism: an unresolved relationship.

Authors:  Mishaela R Rubin; Shonni J Silverberg
Journal:  Endocrine       Date:  2012-10       Impact factor: 3.633

Review 2.  Hyperparathyroidism and Bone Health.

Authors:  Francisco Bandeira; Sara Cassibba
Journal:  Curr Rheumatol Rep       Date:  2015-07       Impact factor: 4.592

Review 3.  The Endocrine Role of Bone in Cardiometabolic Health.

Authors:  Rosemary DeLuccia; May Cheung; Rohit Ramadoss; Abeer Aljahdali; Deeptha Sukumar
Journal:  Curr Nutr Rep       Date:  2019-09

4.  Parathyroid hormone reflects adiposity and cardiometabolic indices but not bone density in normal men.

Authors:  Emma O Billington; Greg D Gamble; Ian R Reid
Journal:  Bonekey Rep       Date:  2016-12-07

5.  Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism.

Authors:  Mazhar Müslüm Tuna; Mustafa Çalışkan; Mustafa Ünal; Taner Demirci; Berçem Ayçiçek Doğan; Kerim Küçükler; Mustafa Özbek; Dilek Berker; Tuncay Delibaşı; Serdar Güler
Journal:  J Bone Miner Metab       Date:  2015-06-09       Impact factor: 2.626

6.  Investigation of insulin resistance in patients with normocalcemic primary hyperparathyroidism.

Authors:  Ilkay Cakir; Kursad Unluhizarci; Fatih Tanriverdi; Gulsah Elbuken; Zuleyha Karaca; Fahrettin Kelestimur
Journal:  Endocrine       Date:  2012-02-12       Impact factor: 3.633

7.  Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms.

Authors:  M Procopio; M Barale; S Bertaina; S Sigrist; R Mazzetti; M Loiacono; G Mengozzi; E Ghigo; M Maccario
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

8.  Transient neonatal hypoparathyroidism in two siblings unmasking maternal normocalcemic hyperparathyroidism.

Authors:  Preamrudee Poomthavorn; Boonsong Ongphiphadhanakul; Pat Mahachoklertwattana
Journal:  Eur J Pediatr       Date:  2007-06-15       Impact factor: 3.183

9.  Effect on bone density of postoperative calcium and vitamin-D supplementation in patients with primary hyperparathyroidism: A retrospective study.

Authors:  Erik Nordenström; Johan Westerdahl; Anders Bergenfelz
Journal:  Langenbecks Arch Surg       Date:  2008-06-11       Impact factor: 3.445

10.  Surgery for patients with primary hyperparathyroidism and negative sestamibi scintigraphy--a feasibility study.

Authors:  Mark Thier; Erik Nordenström; Anders Bergenfelz; Johan Westerdahl
Journal:  Langenbecks Arch Surg       Date:  2009-06-23       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.